Bixiye
P53-16 New Notification Requirement for Outpatient Dialysis Services for Commercial Products and Subscribers in Government Programs
Taariikhda uu dhaqangalayo Barnaamijka: Nov 09, 2016
Natiijooyinka Raadinta
Soo bandhiga 2781 - 2790 ee natiijooyinka 4229
Bixiye
P43R1-16 Updated: Third Party Payments of Premium and/or Cost-Sharing
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2016
Bixiye
P6-17 A New Drug, Emflaza (deflazacort), Will Require Prior Authorization
Taariikhda uu dhaqangalayo Barnaamijka: 27, Feb 2017
Bixiye
P46-16 Changes in Medical Policy IV-87 Spinal Fusion: Lumbar
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 30, 2016
Bixiye
P17-17 Addition of Drug Kisqali to the Self-Administered Oncology Prior Authorization with Quantity Limit Program
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 28, 2017
Bixiye
P22-17 Identified Claims Processing Issues Grid
Taariikhda uu dhaqangalayo Barnaamijka: May 10, 2017
Bixiye
P35-16 Requirement to Submit National Drug Codes and Related Information
Taariikhda dhaqangalka Barnaamijka: Jul 27, 2016
Bixiye
P27-16 Changes to Prior Authorization Requirements for Select Services for Commercial Products
Taariikhda wax ku ool ah ee barnaamijka: Jun 08, 2016
Bixiye
P15-16 Place of Service 53 will be Changed to a Facility Place of Service
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 07, 2016
Bixiye
P20-16 Addition of Uptravi ® and Adempas ® to Existing Drug-Related Prior Authorization Program
Taariikhda uu dhaqangalayo Barnaamijka: May 04, 2016